Literature DB >> 17056548

Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor.

Ankita Garg1, Peter F Barnes, Angel Porgador, Sugata Roy, Shiping Wu, Jagpreet S Nanda, David E Griffith, William M Girard, Nenoo Rawal, Sreerama Shetty, Ramakrishna Vankayalapati.   

Abstract

We previously showed that human NK cells used the NKp46 receptor to lyse Mycobacterium tuberculosis H37Ra-infected monocytes. To identify ligands on H37Ra-infected human mononuclear phagocytes, we used anti-NKp46 to immunoprecipitate NKp46 from NK cells bound to its ligand(s) on H37Ra-infected monocytes. Mass spectrometry analysis identified a 57-kDa molecule, vimentin, as a putative ligand for NKp46. Vimentin expression was significantly up-regulated on the surface of infected monocytes, compared with uninfected cells, and this was confirmed by fluorescence microscopy. Anti-vimentin antiserum inhibited NK cell lysis of infected monocytes, whereas antiserum to actin, another filamentous protein, did not. CHO-K1 cells transfected with a vimentin construct were lysed much more efficiently by NK cells than cells transfected with a control plasmid. This lysis was inhibited by mAb-mediated masking of NKp46 (on NK cells) or vimentin (on infected monocytes). ELISA and Far Western blotting showed that recombinant vimentin bound to a NKp46 fusion protein. These results indicate that vimentin is involved in binding of NKp46 to M. tuberculosis H37Ra-infected mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056548     DOI: 10.4049/jimmunol.177.9.6192

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

Authors:  Julia Herrmann; Hannah Berberich; Jessica Hartmann; Steffen Beyer; Karen Davies; Joachim Koch
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

3.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

Review 4.  Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity.

Authors:  A Fuchs; M Colonna
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

Review 5.  Interactions between the intestinal microbiota and innate lymphoid cells.

Authors:  Vincent L Chen; Dennis L Kasper
Journal:  Gut Microbes       Date:  2013-12-16

6.  Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions.

Authors:  Emily M Plummer; Diane Thomas; Giuseppe Destito; Leah P Shriver; Marianne Manchester
Journal:  Nanomedicine (Lond)       Date:  2012-03-06       Impact factor: 5.307

7.  Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression.

Authors:  Rohan Dhiman; Sambasivan Venkatasubramanian; Padmaja Paidipally; Peter F Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

8.  Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.

Authors:  Soung-Chul Cha; Hong Qin; Shibichakravarthy Kannan; Seema Rawal; Leticia S Watkins; Flavio E Baio; Weiguo Wu; Juliana Ong; Jinsong Wei; Benjamin Kwak; Sang Kim; Michael S Popescu; Daniel S Paick; Kunhwa Kim; Amber Luong; Richard E Davis; Harry W Schroeder; Larry W Kwak; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

9.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

10.  Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1.

Authors:  Praveena S Thiagarajan; Valentin P Yakubenko; Deena H Elsori; Satya P Yadav; Belinda Willard; Carmela D Tan; E René Rodriguez; Maria Febbraio; Martha K Cathcart
Journal:  Cardiovasc Res       Date:  2013-05-13       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.